Evidence map›Paper›PMID 41720098›Full record

ArticleAmerican journal of human genetics2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

Valentina Serpieri, Myriam Vezain-Mouchard, Alessia Orsi, Maryline Lecointre, Concetta Mazzotta, Florent Marguet, Anna Garbelli, Pascale Marcorelles, Ludovica Celli, Alice Goldenberg and 26 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Valentina SerpieriDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Myriam Vezain-MouchardUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Genetics and Reference Center for Developmental Disorders, 76000 Rouen, France.
Alessia OrsiDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Maryline LecointreUniv Rouen Normandie, INSERM U1245, 76000 Rouen, France.
Concetta MazzottaDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Florent MarguetUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Pathology, 76000 Rouen, France.
Anna GarbelliInstitute of Molecular Genetics 'Luigi Luca Cavalli-Sforza', National Research Council (IGM-CNR), 27100 Pavia, Italy.
Pascale MarcorellesCHU Brest, Department of Pathology, 29200 Brest, France.
Ludovica CelliInstitute of Molecular Genetics 'Luigi Luca Cavalli-Sforza', National Research Council (IGM-CNR), 27100 Pavia, Italy.
Alice GoldenbergUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Genetics and Reference Center for Developmental Disorders, 76000 Rouen, France; CH Le Havre, Department of Genetics, 76600 Le Havre, France.
Roberta De MoriInduced Pluripotent Stem Cells and Organoids Unit, IRCCS Santa Luicia Foundation, 00179 Rome, Italy.
Nathalie DrouotUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Genetics and Reference Center for Developmental Disorders, 76000 Rouen, France.
Francesco PetrizzelliBioinformatics Laboratory, IRCSS Casa Sollievo Della Sofferenza, 71013 S. Giovanni Rotondo (FG), Italy.
François JaninUniv Rouen Normandie, INSERM U1245, 76000 Rouen, France.
Gaël NicolasUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Genetics and Reference Center for Developmental Disorders, 76000 Rouen, France.
Noor SmalTranslational Epilepsy Genomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
Claudia CondoluciDevelopmental Disabilities and Rehabilitation, IRCCS San Raffaele Roma, 00166 Rome, Italy.
Carla MariniChild Neurology and Psychiatric Unit, G. Salesi Pediatric Hospital, Azienda Ospedaliera-Universitaria Delle Marche, 60126 Ancona, Italy.
Frederic Tran-Mau-ThemUnité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, and INSERM UMR1231 GAD, 21079 Dijon, France.
Valentin RuaultReference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, 34000 Montpellier, France.
Alessia MicalizziLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy; Medical Genetics Unit, San Pietro Fatebenefratelli Hospital, 00189 Rome, Italy.
Silvia BioneInstitute of Molecular Genetics 'Luigi Luca Cavalli-Sforza', National Research Council (IGM-CNR), 27100 Pavia, Italy.
Tommaso MazzaComputational Biology and Bioinformatics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Anna PichiecchioDepartment of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy; Neuroradiology Department, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Monia GinevrinoParkinson and Movement Disorders Unit, Study Center on Neurodegeneration (CESNE), Department of Neurosciences, University of Padua, 35121 Padua, Italy.
Sarah WeckhuysenTranslational Epilepsy Genomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium; Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, 2610 Antwerp, Belgium; Department of Neurology, University Hospital, 2650 Antwerp, Belgium.
Alice BedoisService de Génétique, Eurofins Biomnis, Lyon, France.
Béatrice DesnousDepartment of Pediatric Neurology, Aix-Marseille University, Marseille, France.
Laurent HermitteNeuroradiology Department at Timone Hospital, Aix-Marseille University, Marseille, France.
Grace RabieHereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
Moien KanaanHereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
Bruno J GonzalezUniv Rouen Normandie, INSERM U1245, 76000 Rouen, France.
Simone SabbionedaInstitute of Molecular Genetics 'Luigi Luca Cavalli-Sforza', National Research Council (IGM-CNR), 27100 Pavia, Italy.
Annie LaquerrièreUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Pathology, 76000 Rouen, France.
Pascale Saugier-VeberUniv Rouen Normandie, INSERM U1245 and CHU Rouen, Department of Genetics and Reference Center for Developmental Disorders, 76000 Rouen, France.
Enza Maria ValenteDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy; Neurogenetics Research Center, IRCCS Mondino Foundation, 27100 Pavia, Italy. Electronic address: enzamaria.valente@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disruption of the complex processes underlying central nervous system development leads to a broad spectrum of brain malformations and neurodevelopmental disorders, often with a genetic cause. Here, we report bi-allelic pathogenic variants in fibronectin type III and SPRY domain-containing 1-like (FSD1L), encoding a protein of unknown function, in eleven individuals, including five fetuses from six unrelated families. The phenotype ranges from severe hydrocephalus, corpus callosum agenesis, and absent pyramid decussation to a neurodevelopmental syndrome characterized by severe intellectual disability, spastic tetraparesis, reduced vision, and epilepsy, associated with corpus callosum agenesis/hypoplasia, mild ventricular dilation, optic nerve hypoplasia, and white matter reduction. This phenotype closely resembles that observed in L1 syndrome, caused by pathogenic variants in L1CAM, encoding a neural adhesion molecule. The knockdown of Fsd1l in mouse embryos recapitulated the ventricular dilation observed in affected fetuses. Immunohistochemical studies in human control fetuses revealed that FSD1L localized to neurons with commissural fate and projection neurons during human development. Induced pluripotent stem cell (iPSC)-derived neural progenitor cells from affected individuals failed to differentiate into premature neurons and to properly form neurospheres while undergoing increased cell death. In neural progenitors, FSD1L localized with microtubules of the mitotic spindle during M phase and to the transition zone and along the axoneme of the primary cilium during interphase. In line with this, fibroblasts from affected individuals exhibited marked alterations of the mitotic spindle and reduced ciliogenesis and ciliary length compared to control cells. Our findings define FSD1L as a microtubule-associated protein implicated in neuronal differentiation, axon guidance, and fasciculation.

Indexed as

Neural Cell Adhesion Molecule L1Neurodevelopmental DisordersAdolescentAllelesAnimalsChildChild, PreschoolFemaleHumansHydrocephalusInduced Pluripotent Stem CellsInfantIntellectual DisabilityMaleMiceNeural Stem CellsNeural Cell Adhesion Molecule L1commissural axon navigationcongenital hydrocephaluscorpus callosumFSD1FSD1LL1CAML1 syndromemicrotubulesmitosisprimary cilium

Identifiers

PMID41720098
PMCPMC13087397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.